ADAM10 in Intestinal Homeostasis and Regeneration
ADAM10 in Intestinal Homeostasis and Regeneration
批准号:
9108378
负责人:
PETER J DEMPSEY
金额:
$29.37万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-07-01 至 2017-06-30
关键词:
AddressAdultAffectAmericanApplications GrantsBiologyCell LineageCell ProliferationCell surfaceCellsChronicChronic DiseaseClinicalDataDiarrheaDiseaseDisintegrinsEnvironmentEventFailureGoalsGrantHomeostasisHumanInborn Genetic DiseasesInflammatory Bowel DiseasesInjuryInterventionIntestinal DiseasesIntestinesKnowledgeKnowledge acquisitionLeadMediatingMetalloproteasesModelingMolecularMolecular TargetMorbidity - disease rateMusNatural regenerationOutcomePathway interactionsPatientsPlayPopulationProliferatingPublic HealthQuality of lifeRegenerative MedicineRegenerative responseRegulationResearchRoleSignal TransductionSignaling MoleculeStem Cell ResearchStem cellsTestingTherapeuticWorkbasecell injuryextracellulargastrointestinalimprovedinjury and repairinnovationinterestintestinal cryptintestinal homeostasisnotch proteinnovel therapeutic interventionnovel therapeuticspreventprogenitorprogramsregenerativesecretasestem cell biologystem cell nichestem cell populationstem cell therapytherapeutic target
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Human intestinal diseases are comprised of a wide variety of pathological states, including chronic illnesses such as inflammatory bowel disease (IBD) and intestinal failure, and thus represent a significant public health burden. A major challenge for intestinal research therefore is to develop a more detailed understanding of intestinal biology that will lead to new interventions to prevent and treat these debilitating intestinal diseases. The long-term goals of my research are to understand the molecular mechanisms that regulate intestinal stem cells (ISCs), and how these pathways can be utilized for regenerative medicine or modulated to improve clinical outcomes and quality of life of patients suffering these chronic illnesses. The objective of this grant is to determine the role of
ADAM10, which is an a-secretase (i.e., ectodomain sheddase) that is predicted to regulate key extracellular signaling events, including Notch signaling in ISCs and their progeny within the stem cell niche. Our central hypothesis is that ADAM10 acts at multiple levels in adult crypts to maintain ISCs and to control progenitor proliferation and lineage specification, and that these same signals play a critical role during intestinal injury and regeneration. Our hypothesis has been formulated on the basis of our own preliminary data us- ing intestine-specific ADAM10-deficient mice. The rationale for the proposed research is that, by understanding the role for ADAM10 signaling in maintaining ISCs/progenitor populations during normal intestinal homeostasis, and in models of injury/regeneration, we will define ADAM10 as a new molecular target, resulting in innovative approaches for stem cell therapies in regenerative medicine and for treatment of intestinal diseases. In Aim 1, we will define the requirements for ADAM10 in distinct ISC populations through cell lineage tracing. In Aim 2, we will determine the requirements for ADAM10 in distinct ISC population in intestinal inju- ry/regeneration. In Aim 3, we will determine the role of ADAM10 in progenitor proliferation and cell lineage specification using conditional ADAM10-deficient mice. At the conclusion of these studies, we will have expanded our knowledge on the importance of ADAM10 signaling in ISC populations during intestinal homeosta- sis under normal and regenerative conditions, evaluated its contribution to the regulation of progenitor cell proliferation and cell fate decisions, and determined the significance of ADAM10-mediated Notch signaling in these events.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Are Facultative Reserve ISCs the Cellular Origin of Familial Small Intestinal Neuroendocrine Tumors?
兼性储备 ISC 是家族性小肠神经内分泌肿瘤的细胞起源吗?
DOI:
10.1053/j.gastro.2016.05.020
发表时间:
2016
期刊:
Gastroenterology
影响因子:
29.4
作者:
[Dempsey,PeterJ]
通讯作者:
Dempsey,PeterJ
Mucus Detachment by Host Metalloprotease Meprin β Requires Shedding of Its Inactive Pro-form, which Is Abrogated by the Pathogenic Protease RgpB.
宿主金属蛋白酶 Meprin β 的粘液分离需要脱落其非活性前体形式,而该前体形式可被致病性蛋白酶 RgpB 消除。
DOI:
10.1016/j.celrep.2017.10.087
发表时间:
2017
期刊:
Cell reports
影响因子:
8.8
作者:
[Wichert,Rielana, Ermund,Anna, Schmidt,Stefanie, Schweinlin,Matthias, Ksiazek,Miroslaw, Arnold,Philipp, Knittler,Katharina, Wilkens,Frederike, Potempa,Barbara, Rabe,Björn, Stirnberg,Marit, Lucius,Ralph, Bartsch,JörgW, Nikolaus,Susanna, Falk-]
通讯作者:
Falk-
ADAM Proteases and Gastrointestinal Function.
ADAM 蛋白酶和胃肠功能。
DOI:
10.1146/annurev-physiol-021014-071720
发表时间:
2016
期刊:
Annual review of physiology
影响因子:
18.2
作者:
[Jones JC, Rustagi S, Dempsey PJ]
通讯作者:
Dempsey PJ
Fluorescent substrates useful as high-throughput screening tools for ADAM9.
荧光底物可用作 ADAM9 的高通量筛选工具。
DOI:
10.2174/138620710791054259
发表时间:
2010
期刊:
Combinatorial chemistry & high throughput screening
影响因子:
1.8
作者:
[Moss,MarciaL, Rasmussen,FredH, Nudelman,Raphael, Dempsey,PeterJ, Williams,Jason]
通讯作者:
Williams,Jason
DOI:
10.21037/sci.2016.09.15
发表时间:
2016-10
期刊:
Stem cell investigation
影响因子:
--
作者:
[Jennifer C. Jones;P. Dempsey]
通讯作者:
Jennifer C. Jones;P. Dempsey
Disease Modeling Core
-
批准号:10392981
-
项目类别:
-
资助金额:$17.82万
-
财政年份:2020
-
负责人:PETER J DEMPSEY
-
依托单位:
ADAM10 in Intestinal Homeostasis and Regeneration
-
批准号:8734396
-
项目类别:
-
资助金额:$29.28万
-
财政年份:2012
-
负责人:PETER J DEMPSEY
-
依托单位:
ADAM10 in Intestinal Homeostasis and Regeneration
-
批准号:8475585
-
项目类别:
-
资助金额:$29.18万
-
财政年份:2012
-
负责人:PETER J DEMPSEY
-
依托单位:
ADAM10 in Intestinal Homeostasis and Regeneration
-
批准号:8371729
-
项目类别:
-
资助金额:$30.44万
-
财政年份:2012
-
负责人:PETER J DEMPSEY
-
依托单位:
Development of ADAM10 Prodomain as a Therapeutic Agent
-
批准号:7674433
-
项目类别:
-
资助金额:$10.74万
-
财政年份:2009
-
负责人:PETER J DEMPSEY
-
依托单位:
Endogenous Betacellulin Signaling in Beta-cell Biology
-
批准号:7091459
-
项目类别:
-
资助金额:$32.91万
-
财政年份:2002
-
负责人:PETER J DEMPSEY
-
依托单位:
Endogenous Betacellulin Signaling in Beta-cell Biology
-
批准号:6574863
-
项目类别:
-
资助金额:$39.38万
-
财政年份:2002
-
负责人:PETER J DEMPSEY
-
依托单位:
Endogenous Betacellulin Signaling in Beta-cell Biology
-
批准号:6897432
-
项目类别:
-
资助金额:$39.38万
-
财政年份:2002
-
负责人:PETER J DEMPSEY
-
依托单位:
Endogenous Betacellulin Signaling in Beta-cell Biology
-
批准号:6779889
-
项目类别:
-
资助金额:$39.38万
-
财政年份:2002
-
负责人:PETER J DEMPSEY
-
依托单位:
Endogenous Betacellulin Signaling in Beta-cell Biology
-
批准号:6665328
-
项目类别:
-
资助金额:$39.38万
-
财政年份:2002
-
负责人:PETER J DEMPSEY
-
依托单位:
Processing of EGF Ligands in Gut Biology and Cancer
-
批准号:6785414
-
项目类别:
-
资助金额:$28.18万
-
财政年份:2000
-
负责人:PETER J DEMPSEY
-
依托单位:
Processing of EGF Ligands in Gut Biology and Cancer
-
批准号:6613839
-
项目类别:
-
资助金额:$28.18万
-
财政年份:2000
-
负责人:PETER J DEMPSEY
-
依托单位:
Processing of EGF Ligands in Gut Biology and Cancer
-
批准号:6345608
-
项目类别:
-
资助金额:$28.18万
-
财政年份:2000
-
负责人:PETER J DEMPSEY
-
依托单位:
AMPHIREGULIN PROCESSING IN HUMAN KERATINOCYTES
-
批准号:6325737
-
项目类别:
-
资助金额:$8.53万
-
财政年份:2000
-
负责人:PETER J DEMPSEY
-
依托单位:
Processing of EGF Ligands in Gut Biology and Cancer
-
批准号:7116696
-
项目类别:
-
资助金额:$16.63万
-
财政年份:2000
-
负责人:PETER J DEMPSEY
-
依托单位:
Processing of EGF Ligands in Gut Biology and Cancer
-
批准号:6382025
-
项目类别:
-
资助金额:$28.18万
-
财政年份:2000
-
负责人:PETER J DEMPSEY
-
依托单位:
Processing of EGF Ligands in Gut Biology and Cancer
-
批准号:6524534
-
项目类别:
-
资助金额:$28.18万
-
财政年份:2000
-
负责人:PETER J DEMPSEY
-
依托单位:
AMPHIREGULIN PROCESSING IN HUMAN KERATINOCYTES
-
批准号:6100584
-
项目类别:
-
资助金额:$8.53万
-
财政年份:1999
-
负责人:PETER J DEMPSEY
-
依托单位:
AMPHIREGULIN PROCESSING IN HUMAN KERATINOCYTES
-
批准号:6268401
-
项目类别:
-
资助金额:$6.66万
-
财政年份:1998
-
负责人:PETER J DEMPSEY
-
依托单位:
海外基金